SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fortis Healthcare slips on the buzz that DGHS has slapped Rs 503 crore fine on EHIRCL

13 Jun 2016 Evaluate

Fortis Healthcare is currently trading at Rs. 162.90, down by 5.30 points or 3.15% from its previous closing of Rs. 168.20 on the BSE.

The scrip opened at Rs. 163.80 and has touched a high and low of Rs. 163.80 and Rs. 160.10 respectively. So far 48,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 199.20 on 05-Aug-2015 and a 52 week low of Rs. 141.10 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 168.90 and Rs. 160.10 respectively. The current market cap of the company is Rs. 7,549.00 crore.

The promoters holding in the company stood at 71.28% while Institutions and Non-Institutions held 18.10% and 10.62% respectively.

Directorate General of Health Services (DGHS) has reportedly slapped a total fine of Rs 503 crore on Escort Heart Institute & Research Centre (EHIRCL), a subsidiary of Fortis Healthcare, for non-compliance of conditions of land allotment lease. Delhi Development Authority (DDA) had granted the land to the hospital on the condition that it would provide free treatment to 25 per cent of its patients. However, in 2005, the company contested that just 10 per cent of the seven acres of land was granted with this condition.

Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care speciality and hospitals, with a healthcare network spanning 9 countries.


Fortis Healthcare Share Price

889.75 15.45 (1.77%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×